Equites Radar

CVS · CVS Health Corporation

Healthcare PlansUnited StatesAnalyst view: Strong Buy

$106.89

-0.49% last session

End-of-day data · updated 2026-07-25

Bullish4 bullish · 1 bearish technical signals
Consensus: Buy (1.50 from 26 analysts)
To mean target: +5.0%

Market cap

$137B

Enterprise value

$204B

Trailing P/E

47.3

Forward P/E

12.8

Dividend yield

2.0%

Beta

0.60

Avg volume

8M

Employees

219K

2D change

0.80%

5D change

0.74%

10D change

2.36%

30D change

3.58%

60D change

19.48%

MTD change

3.43%

YTD change

38.93%

Analyst Outlook

Consensus ratingBuy
Recommendation mean (1–5)1.50
Covering analysts26
Mean price target$112.19
Low price target$79.00
Upside to mean target+5.0%

Analyst estimates change daily — follow the shifts on the Estimate Trends page.

Technical Analysis

RSI (14)61.8
50-day MA$99.24
200-day MA$82.45
Price vs 50-day MA+7.7%
Price vs 200-day MA+29.6%
MACD histogram-0.06
Volume vs 3-month avg0.7×
52w low $56.9452w high $109.92

Analyst sentiment over time — CVS

Rec Mean (blue, left — higher = more bullish) vs. price targets (right).

Investment Bank Ratings as of 2026-07-25

Latest call per bank · past 12 months

UBS

Buy

$122

+14.1% vs price
▲ raised from $115Maintains · 2026-07-25

Wells Fargo

Overweight

$123

+15.1% vs price
▲ raised from $103Maintains · 2026-07-13

RBC Capital

Outperform

$113

+5.7% vs price
▲ raised from $107Maintains · 2026-07-09

Bank of America

Buy

$110

+2.9% vs price
▲ raised from $100Maintains · 2026-06-23

Morgan Stanley

Overweight

$111

+3.8% vs price
▲ raised from $106Maintains · 2026-06-04

Barclays

Overweight

$106

-0.8% vs price
▲ raised from $101Maintains · 2026-05-26

JP Morgan

Overweight

$111

+3.8% vs price
▲ raised from $101Maintains · 2026-05-12

Goldman Sachs

Buy

$91.00

-14.9% vs price
▲ raised from $0.00Initiates · 2025-10-14

Recent rating actions

DateFirmActionRatingPrice target
2026-07-25UBSMaintainsBuy$115 $122
2026-07-14Truist SecuritiesMaintainsBuy$108 $118
2026-07-13Wells FargoMaintainsOverweight$103 $123
2026-07-09RBC CapitalMaintainsOutperform$107 $113
2026-07-07Cantor FitzgeraldMaintainsOverweight$100 $110
2026-06-23Bank of AmericaMaintainsBuy$100 $110
2026-06-08MizuhoMaintainsOutperform$110 $115
2026-06-04Morgan StanleyMaintainsOverweight$106 $111

Ratings and price targets are the published opinions of the issuing banks, compiled from Yahoo Finance rating actions — not investment advice.

Signal Summary as of 2026-07-23

  • RSI (14): RSI is 62 — neutral momentum, neither overbought nor oversold.
  • Price vs 50-day MA: Trading 7.7% above the 50-day MA ($99.24).
  • Price vs 200-day MA: Trading 29.6% above the 200-day MA ($82.45).
  • MA cross: The 50-day MA sits above the 200-day MA (golden-cross regime) — the longer-term trend points up.
  • MACD (12,26,9): MACD histogram is negative (-0.06) — short-term momentum is fading.
  • 52-week range: Price is within 5% of the 52-week high ($109.92).

CVS Price Chart

Loading chart for CVS

Fundamentals

Revenue (TTM)$406B
EBITDA$15B
Free cash flow$5.0B
Operating cash flow$10B
Book value / share$60.84
Net debt / EBITDA4.3
WACC7.0%
Revenue growth6.00%
Earnings growth63.00%

About CVS Health Corporation

CVS Health Corporation provides health solutions in the United States. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services, including medical, pharmacy, dental, and behavioral health plans; medical management capabilities; Medicare Advantage and Medicare Supplement plans; prescription drug plans (PDPs); and Medicaid health care management services. It serves employer groups, individuals, college students, part-time and hourly workers, health plans, health care providers, governmental units, government-sponsored plans, labor groups, and expatriates. The Health Services segment offers pharmacy benefit management solutions, including plan design and administration, formulary management, retail pharmacy network management, specialty and mail-order pharmacy, clinical services, disease management, medical spend management services, and pharmacy and other administrative services. It serves employers, insurance companies, unions, government employee groups, health plans, PDPs, Medicaid managed care plans, CMS, plans offered on public health insurance exchanges, and other sponsors of health benefit plans. The Pharmacy & Consumer Wellness segment sells prescription and over-the-counter drugs, consumer health and beauty products, personal care products, and other general merchandise products. This segment also distributes prescription drugs; and provides related pharmacy consulting and other ancillary services to care facilities and other care settings. It operates online retail pharmacy websites, retail specialty pharmacy stores, and compounding pharmacies, as well as branches for infusion and enteral nutrition services. The company was formerly known as CVS Caremark Corporation and changed its name to CVS Health Corporation in September 2014. CVS Health Corporation was founded in 1963 and is headquartered in Woonsocket, Rhode Island.

More in Healthcare Plans

Screen CVS against the full market on the Radar →

Data is sourced from end-of-day snapshots and refreshed daily before the US market open — nothing on this page is real-time. Figures can contain vendor errors. This page is for information only and is not investment advice.